Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kopran
Mumbai, Maharashtra, Indiakopran.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Kopran is a fully integrated Indian pharmaceutical company commercializing an extensive portfolio of finished dosage forms and active pharmaceutical ingredients (APIs) globally, with facilities accredited by major international regulatory agencies. Kopran products are marketed in over 60 countries and the company focuses on both regulated and emerging markets, with a particular strength in generic solid oral dosages and dry powder formulations in the antibiotics and cardiovascular areas[1][3][5][7].
- Therapeutic areas
- EndocrinologyRheumatologyInfectious DiseasesCardiovascularOtherNeurology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Kopran.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kopran.